Attenuated Vaccines
Attenuated vaccines use live pathogens engineered or selected to replicate minimally, inducing broad humoral and cellular immunity and often mucosal responses. They can confer rapid, durable protection with dose-sparing potential, but require optimized genetic stability, thermostability, manufacturability, and safety profiling for deployment in military environments.
Technical Challenges
Risk of reversion to virulence or residual pathogenicity in immunocompromised or polytrauma patients
Cold-chain dependence and limited thermostability that constrain austere deployment
Scalable GMP manufacturing and lot-to-lot consistency for complex live biologicals
Regulatory and safety demonstration for genetically modified live organisms in field settings
Emerging Opportunities
Genetic attenuation strategies ensuring irreversible, multi-locus attenuation to prevent reversion
Formulations enabling prolonged ambient stability and simple field reconstitution or needle-free delivery
Validated safety profiles for soldiers with varied immunologic status, including those with trauma or immune-suppressing conditions
Rapid manufacturing platforms and bridging studies tailored to emergent threat pathogens
Current and Emerging Technologies in Attenuated Vaccines
Rational genetic attenuation and synthetic biology
Targeted deletions, codon deoptimization, and multi-gene attenuation reduce reversion risk while preserving immunogenicity; synthetic biology enables rapid design against novel threats.
Thermostable formulations and lyophilization
Lyophilized and excipient-optimized vaccines, sugar-glass matrices, and novel stabilizers reduce cold-chain dependence for forward-deployed units.
Alternative delivery systems
Mucosal (intranasal/aerosol) and microneedle patch platforms enable rapid mass administration, dose-sparing, and improved mucosal immunity relevant to respiratory threats.
Advanced adjuvant and immune-modulatory approaches
Adjuvants and host-directed formulations tailor innate activation to enhance safety and durability while minimizing reactogenicity in stressed warfighter populations.
Modular rapid-manufacturing and quality control
Platform-based GMP workflows, digital in-process controls, and molecular potency assays shorten time-to-clinic for emergent pathogen vaccines.
Importance to Military Medicine
Force readiness and outbreak containment
Rapidly deployable vaccines protect personnel from infectious threats, preserving unit cohesion and mission capability during outbreaks or deployments.
Austere and prolonged-field care suitability
Thermostable, single-dose or mucosal attenuated vaccines reduce logistic burden and enable protection when evacuation or delivery infrastructure is limited.
Compatibility with combat casualty care realities
Safety profiles that account for polytrauma, immunomodulation, and concurrent therapies are essential for vaccinating wounded or medically complex service members.
Surge capacity for biodefense and novel threats
Platform attenuated vaccines support rapid response to emerging biological threats and deliberate attacks with scalable production and pre-existing safety frameworks.
Alignment with the MTEC Mission
Directly advances MTEC’s DoD-focused mission by accelerating development of medical countermeasures that sustain warfighter health and operational readiness.
Aligns with MTEC’s broad portfolio spanning infectious disease, biodefense, and prolonged/distributed care through platform-based vaccine technologies.
Supports rapid transition from research to field-ready solutions via consortium-enabled public–private partnerships, GMP bridging, and DoD-directed studies.
Dual-Use (Military + Civilian) Applications
Dual-use value: attenuated vaccines developed for military threats translate directly to civilian public health needs for pandemic preparedness and endemic disease control.
Technology spillover to civilian markets includes thermostable formulations, needle-free delivery, and rapid manufacturing platforms that benefit hospitals and global health programs.
Regulatory pathways and safety data generated under DoD partnerships accelerate licensure and emergency use authorizations for dual-use applications.
Collaborative clinical trials and field evaluations produce evidence applicable to civilian mass-vaccination, outbreak response, and low-resource settings.
Explore MTEC Members with Attenuated Vaccines Capabilities
MTEC members bring multidisciplinary strengths—academic immunology, industrial-scale GMP manufacturing, synthetic biology, clinical trial networks, and DoD operational medicine—to advance attenuated vaccine candidates from design to deployment.
Members contribute rapid prototyping, thermostability formulation expertise, forward-deployable delivery platforms, and access to military clinical sites for pivotal evaluations.
Explore member profiles to identify partners with GMP capacity, regulatory experience, and operational medical insight to co-develop attenuated vaccine solutions for the Warfighter and civilian populations.
89 Members with Attenuated Vaccines capabilities.
The University of Texas System is a leading public university system in the United States, dedicated to improving lives through education, health care, and research. With over 256,000 students enrolled across 14 institutions, the UT System is committed to providing affordable access to higher education and producing a skilled workforce to drive Texas's economy.
Georgia Southern University is a vibrant institution with over 26,100 students across three campuses in Statesboro, Savannah, and Hinesville. The university offers 132 degree programs at the associate, bachelor’s, master’s, and doctorate levels, emphasizing student success, community impact, and research excellence. With a commitment to inclusivity and engagement, Georgia Southern fosters a supportive environment for diverse learners, including military-affiliated and adult students. The university is dedicated to transforming lives through education and community engagement, aligning its programs with regional needs. Additionally, Georgia Southern provides accelerated pathways for students to fast-track their master's degrees, enhancing educational opportunities. The university also emphasizes career readiness and public impact research, preparing students for successful careers and contributing to community development.
STAT Therapeutics is focused on developing a drug- device combination for easy, rapid administration of intramuscular, life-saving medications by users in any setting, aiming to improve access and usability for acute emergency treatments such as pain, anaphylaxis, and seizures.
The University of Texas at San Antonio (UTSA) is dedicated to the advancement of knowledge through research, teaching, and community engagement. As a premier public research university, UTSA embraces multicultural traditions and serves as a catalyst for socioeconomic development, providing access to educational excellence and preparing citizen leaders for the global environment.
The Precision Vaccines Program (PVP), based in the Department of Pediatrics at Boston Children’s Hospital, is an academic research initiative dedicated to discovering and developing next-generation vaccines tailored to vulnerable populations. PVP conducts both basic and translational research to create novel vaccines and therapeutics for diseases that disproportionately affect infants, older adults, and immunocompromised individuals. The program brings together experts in vaccinology, clinical trials, immunology, molecular biology, data management, biostatistics, bioinformatics, and systems biology, fostering international collaboration among academia, government, and industry to advance precision medicine in vaccinology.
Auburn University Research & Economic Development is dedicated to advancing research and economic growth through a collaborative effort among its various colleges and departments. The organization focuses on fostering innovation, supporting faculty and student research, and facilitating partnerships with industry and government to address societal challenges and enhance the quality of life. Recent initiatives include the launch of the Team Science Series to promote interdisciplinary collaboration and the development of the Gulf Coast Engineering Research Station to address coastal environmental challenges.
The Institute for Integrative & Innovative Research (I³R) at the University of Arkansas is dedicated to pioneering solutions to wicked problems and societal challenges through convergence research. With a mission to advance research excellence and stimulate economic development, I³R focuses on deploying innovations at scale through collaboration across various sectors, including academia, industry, and government.
UTMB is dedicated to supporting research, education, and scholarly endeavors, with a focus on creating the future of healthcare through innovative research and community engagement.
Revolution Biomanufacturing Inc. (RBIx) is expanding beyond traditional CDMO Process/Analytical Development and Manufacturing services to pioneer distributed molecular manufacturing. A new class of digital biomanufacturing that enables the autonomous design, manufacture, quality verification, and deployment of Nucleic Acid therapeutics and molecular diagnostics at the point of need. By integrating AI-driven sequence optimization, enzymatic nucleic acid synthesis, Nanoparticle design and manufacturing (LNP & EV), closed-loop quality control, and field-deployable manufacturing platforms, RBIx is creating adaptive biological infrastructure capable of responding to emerging diseases, national security threats, and personalized medicine with unprecedented speed and flexibility.
The University of Chicago is a prestigious urban research university committed to rigorous inquiry and intellectual freedom. Founded in 1890, it has produced numerous Nobel laureates and is known for its transformative education and groundbreaking research across various fields. The university fosters an inclusive and diverse learning environment, encouraging participation from all community members.
Boston University is a major research institution committed to leading breakthroughs across various disciplines. The Office of Research supports and advances research excellence, fostering collaboration among researchers, industry partners, and government leaders to address significant societal challenges.
Baylor University is a preeminent Christian research university committed to addressing the world's most meaningful challenges through top-tier research and scholarship. Recognized as an R1 research institution, Baylor focuses on infusing its distinct Christian mission into its research initiatives, fostering a commitment to excellence and innovation.
Founded in 2016, Maxwell Biosciences is a preclinical stage biotechnology company focused on developing innovative therapeutics targeting viruses, bacteria, fungi, and biofilm formations. Utilizing a unique drug-discovery platform, the company aims to create affordable and effective health solutions to combat infectious diseases and enhance healthspan.
Base Pair Biotechnologies specializes in custom aptamer discovery and development for research, diagnostics, therapeutics, and industrial applications. The company leverages proprietary multiplex selection, advanced bioinformatics, and chemical modification techniques to develop high-affinity and selective nucleic acid aptamers. Base Pair enables affinity reagent development, biosensor design, and molecular detection for a broad range of targets and partners across academia and industry.
The Nanovaccine Institute, established at Iowa State University in 2017, is a national transdisciplinary research consortium focused on advancing nano-based technologies to treat and prevent diseases. The institute aims to revolutionize public health outcomes through the design and promotion of nano-based vaccines and therapeutics.
The UT Arlington Research Institute (UTARI) specializes in applying cutting-edge technologies to real-world engineering problems. Our collaborative endeavors reflect a commitment to excellence, integrity, and respect for all, bringing economic growth and fulfillment to our families, business partners, university, and community.
Safi Biotherapeutics
Next-Generation Manufactured Red Blood Cells for Extended Battlefield Blood Supply: Safi Biotherapeutics
Safi Biotherapeutics is developing manufactured red blood cells (mRBCs) with extended shelf life to improve battlefield transfusion readiness and emergency trauma care.
Non-Invasive Glymphatic (GF) Monitoring and Recovery Optimization for Warfighter Cognitive Readiness
Applied Cognition is developing non-invasive glymphatic monitoring and recovery technologies to enhance warfighter cognitive readiness, resilience, and sleep recovery.
Moberg Analytics
Moberg Analytics – Advanced Brain Monitoring & Critical Care Informatic
Moberg’s platform unifies brain monitoring data for faster, precise treatment of severe brain injuries in military and civilian care.
University of California San Francisco
TemPredict: AI-Driven Wearable Monitoring for Early Illness Detection and Warfighter Readiness
TemPredict: AI wearables detect early illness and health risks to support warfighter readiness.